Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
FDNA
Mar 21, 2017,
Phoenix, AZ (PRWEB) — FDNA announces the launch of Face2Gene RESEARCH, an application in the Face2Gene Suite that uses facial analysis, deep learning, and artificial intelligence to analyze patient cohorts to make genomic discoveries. The announcement was made this week at the 2017 American College of Medical Genetics and Genomics (ACMG).
The new Face2Gene RESEARCH application enables clinicians worldwide to test scientific hypotheses using the de-identified data from the patients they routinely see, paving the way for advancement in research on genomics and rare diseases at an unprecedented pace. The analysis instantly identifies the facial characteristics, phenotypes, and genes that are potentially indicative of syndromes, to increase understanding of diseases and support diagnostic and therapeutic research.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…